newsfilter
← Latest News
PR Newswire·

Lipocine to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Lipocine Inc. (NASDAQ: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced that Company...